Blog Search

SAB Biotherapeutics Produces New Human Antibody Treatment for MERS-CoV

DiversitAb™ platform provides rapid response to emerging infectious diseases Sioux Falls, S.D.,– SAB Biotherapeutics, Inc. (SAB), a leading biopharmaceutical development company, announced today it has produced a new human antibody therapeutic to treat t…
DiversitAb™ platform provides rapid response to emerging infectious diseases Sioux Falls, S.D., – SAB Biotherapeutics, Inc. (SAB), a leading biopharmaceutical development company… http://www.sdbio.org/index.php/blog/2016/02/sab-biotherapeutics-produces-new-human-antibody-treatment-mers-cov/